HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 21, No 11, November 2017 – Paediatric Illnesses       » Breakthrough new rice variety announced in Northern China       » Ebola vaccine approved in China       » Study reveals anti-cancer properties of a fungus used in traditional medicine       » Chinese scientists create genetically modified low-fat pigs       » China, Brazil and Russia are riskiest markets for compliance and regulation       » Why are Korean eggs salmonella-free?      
BIOBOARD For e-subscribers (PDF)
Vol 21, No 03, March 2017
SINGAPORE
Letting Go

Researchers from the Mechanobiology Institute, Singapore (MBI) at the National University of Singapore have described how dying cells detach and are expelled from a tissue, and how tissue tension in the region surrounding a dying cell is remodelled. The work was published online in the scientific journal Development in November 2016. The tissues in our bodies, such as epithelial, nervous or muscle tissue...

SINGAPORE & JAPAN
ASLAN Pharmaceuticals Announces First Patient Enrolled in Phase 1 Study of Varlitinib in Japan

SINGAPORE - ASLAN Pharmaceuticals (ASLAN), a biotech company focused on the development of immunotherapies and targeted agents for Asia prevalent tumour types, announced that they are initiating enrolment of the first patient in the phase 1 clinical trial for varlitinib (ASLAN001) in biliary tract cancer in Japan. Varlitinib is a potent reversible small molecule inhibitor of the HER-family of...

JAPAN & UNITED STATES
Santen and twoXAR Announce Strategic Research Collaboration to Discover New Glaucoma Treatments

Emeryville, CA and Palo Alto, CA - Santen, Inc., the U.S. subsidiary of Santen Pharmaceutical Co., Ltd., the specialty ophthalmology company headquartered in Osaka, Japan, and twoXAR, Inc., an artificial intelligence-driven biopharmaceutical company, announced on Feb 23 that the two companies have entered into a strategic research collaboration focused on the identification of new drug candidates...

UNITED STATES
New Study Finds Extensive Use of Fluorinated Chemicals in Fast Food Wrappers

Americans may be consuming fast food wrapped in paper treated with perfluorinated chemicals (PFCs) - the same chemicals used in stain-resistant products, firefighting materials and nonstick cookware, according to a new study published in the journal Environmental Science & Technology. Researchers tested more than 400 samples of packaging materials, including hamburger and sandwich wrappers...

What Doesn't Kill You Makes You Stronger

La Jolla, Calif. - Biologists have known for decades that enduring a short period of mild stress makes simple organisms and human cells better able to survive additional stress later in life. Now, scientists at Sanford Burnham Prebys Medical Discovery Institute (SBP) have found that a cellular process called autophagy is critically involved in providing the benefits of temporary stress. The study, published in...

Non-Invasive Test Offers Quick Skin Cancer Diagnosis

Researchers funded by the National Institute of Biomedical Imaging and Bioengineering have developed a non-invasive imaging technique that accurately detects skin cancer without surgical biopsy. Multiphoton microscopy of mitochondria-small organelles that produce energy in cells-accurately identified melanomas and basal cell carcinomas by detecting abnormal clusters of mitochondria in...

Life Under Pressure

Washington, D.C. - Life can thrive in some of the most extreme environments on the planet. Microbes flourish inside hot geothermal vents, beneath the frigid ice covering Antarctica and under immense pressures at the bottom of the ocean. For these organisms to survive and function, so must the enzymes that enable them to live and grow. Now, researchers from Georgetown University have homed in on...

AUSTRALIA & THAILAND
Commencement of BIT225 Phase 2 HIV-1 Clinical Trial

Sydney, AUSTRALIA - The Directors of Biotron Limited are pleased to announce that the Company has commenced a Phase 2 human clinical trial (BIT225-009) with its lead antiviral drug BIT225. The trial is a Phase 2, multi-centre, randomised, placebo-controlled, double-blind study of BIT225 and Combination Antiretroviral Therapy (cART): Atripla? in patients with Human Immunodeficiency Virus (HIV-1) infection...

CANADA
Understanding the Genetics of Human Height

MONTREAL - A large-scale international study involving more than 300 researchers from five continents and 700,000 participants, published on Feb. 1 in Nature, heralds the discovery of 83 genetic variations controlling human height. Guillaume Lettre, a professor at Université de Montréal's Faculty of Medicine and researcher at the Montreal Heart Institute, co-led the study with professors Joel N. Hirschhorn of...

TAIWAN
TLC Announces Collaboration with CMUH in Exploring Solutions for Unmet Medical Needs in Oncology and Osteoarthritis

TLC and China Medical University Hospital (CMUH) signed an agreement on Feb 22 to collaborate in the execution of four clinical trial programs, including two oncology candidate therapeutics and one therapeutic for extended duration osteoarthritis treatment. These drugs were developed by TLC to address unmet medical needs in these areas. By entering a collaboration with the preeminent Clinical...

NEWS CRUNCH  
news MIT Technology Review announces 2018's 10 'Innovators Under 35 Asia'
news Novogen becomes Kazia Therapeutics
news Transforming healthcare through innovation: addressing unmet healthcare needs in Asia Pacific
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Healthcare Focus: LUNGS
February:
War on CANCER
March:
Get to Know TCM
April:
Diabetes: The Big Picture
May:
The Piece of Your Mind - Brain Health/Science
June:
Advocacies in Support of Rare Disease Patients
July:
Food Science & Technology
August:
Eye – the Window to your Soul
September:
Infectious Diseases
October:
A change of heart — Cardiovascular diseases
November:
Paediatric Illnesses
December:
Skin Diseases/Allergic Reactions
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2017 World Scientific Publishing Co Pte Ltd  •  Privacy Policy